Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Lingxiang Tablets for chronic pelvic pain due to sequelae of pelvic inflammatory disease
CTR20243390Phase 2Completed
- Sponsor
- Zhejiang Lukang Pharmaceutical
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lingxiang Tablets in Pelviabdominal infection, chronic prostatitis (CP), sponsored by Zhejiang Lukang Pharmaceutical. Started Sep 2024; status: completed.
02
Drugs
Lingxiang Tablets
03
Conditions
Pelviabdominal infectionchronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20243390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243390.